InflaRx Announces Positive Initial Data from Ongoing Phase IIa O
IFRX: InflaRx N.V.
2020-02-26 07:30:10
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
2020-02-26 07:30:10
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum